Showing results (331-340 of 421) with videos related to

Sort By:
Pageof 43
Molecular Psychiatry|June 29, 2011
Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3L Sha, L MacIntyre, J A Machell, et al.
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Pharmacogenetics and Genomics|September 25, 2013
Predictors of consent to pharmacogenomics testing in the IDEAL studyAlison B Jazwinski, Paul J Clark, Alexander J Thompson, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Human Molecular Genetics|May 18, 2000
Disruption of two novel genes by a translocation co-segregating with schizophreniaJ K Millar, J C Wilson-Annan, S Anderson, et al.
Hepatology Communications|July 5, 2024
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitisDouglas Thorburn, Diana J Leeming, William T Barchuk, et al.
Molecular Genetics and Metabolism Reports|November 25, 2021
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type IIIGhada Hijazi, Anna Paschall, Sarah P Young, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 24, 2007
A genome-wide linkage study in families with major depression and co-morbid unexplained swellingCarl A Anderson, Alan Maclean, Matthew G Dunnigan, et al.
Psychiatric Genetics|August 30, 2001
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorderR S Devon, S Anderson, P W Teague, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic responseZiad F Gellad, Andrew J Muir, John G McHutchison, et al.
Pageof 43